Lance Friedman 13D and 13G filings for Aspire BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-23 7:48 pm Sale | 2025-04-21 | 13G | Aspire BioPharma, Inc. ASBP | Lance Friedman | 4,035,733 8.250% | -16,000 (-0.39%) | Filing |
| 2025-04-17 4:22 pm Sale | 2025-04-11 | 13G | Aspire BioPharma, Inc. ASBP | Lance Friedman | 4,051,733 8.280% | -131,642 (-3.15%) | Filing |
| 2025-04-11 4:55 pm Sale | 2025-04-04 | 13G | Aspire BioPharma, Inc. ASBP | Lance Friedman | 4,183,375 8.550% | -209,500 (-4.77%) | Filing |
| 2025-04-04 5:28 pm Sale | 2025-03-26 | 13G | Aspire BioPharma, Inc. ASBP | Lance Friedman | 4,392,875 8.980% | -46,500 (-1.05%) | Filing |
| 2025-03-28 5:29 pm Sale | 2025-03-19 | 13G | Aspire BioPharma, Inc. ASBP | Lance Friedman | 4,439,375 9.078% | -170,000 (-3.69%) | Filing |
| 2025-03-20 9:58 pm Sale | 2025-03-03 | 13G | Aspire BioPharma, Inc. ASBP | Lance Friedman | 4,609,375 9.462% | -195,000 (-4.06%) | Filing |
| 2025-03-12 4:05 pm Sale | 2025-03-03 | 13G | Aspire BioPharma, Inc. ASBP | Lance Friedman | 4,804,375 9.825% | -79,000 (-1.62%) | Filing |
| 2025-02-26 9:20 pm Purchase | 2025-02-17 | 13G | Aspire BioPharma, Inc. ASBP | Lance Friedman | 4,883,375 9.980% | 4,883,375 (New Position) | Filing |